Transgender HealthPub Date : 2024-12-16eCollection Date: 2024-12-01DOI: 10.1089/trgh.2023.0051
Nicole Finney, Remy Slomoff, Brit Cervantes, Natassia Dunn, Sami Strutner, Crystall Martinez, Jeffrey Vu, Ajanta Naidu, Dylan Hanami, John Billimek
{"title":"Physical and Mental Changes Reported by Transgender and Non-Binary Users of Commercial and Non-Commercial Chest Binders: A Community-Informed Cross-Sectional Observational Study.","authors":"Nicole Finney, Remy Slomoff, Brit Cervantes, Natassia Dunn, Sami Strutner, Crystall Martinez, Jeffrey Vu, Ajanta Naidu, Dylan Hanami, John Billimek","doi":"10.1089/trgh.2023.0051","DOIUrl":"10.1089/trgh.2023.0051","url":null,"abstract":"<p><strong>Purpose: </strong>There are no standardized chest binding guidelines available to health care providers serving transgender and nonbinary individuals, exacerbating the significant health disparities affecting this community. Our study aimed to demonstrate the need for further evidence-based investigations into the association between chest binder type and health outcomes.</p><p><strong>Methods: </strong>For this cross-sectional observational study, a community-engaged online survey evaluating individuals' experiences with their current or most recent chest binder was distributed to LGBTQ+ community centers, online forums, and clinics from July to November 2021. Participants rated their frequency of health outcomes in terms of both positive and negative changes, and the average score was calculated.</p><p><strong>Results: </strong>Of 197 participants, 80% reported using commercial binders as their current or most recent binder type. Users of commercial binders reported significantly more positive mental health changes than noncommercial binders (<i>p</i>=0.043). There was no statistically significant association between negative outcomes and the binder category (<i>p</i>=0.595). Musculoskeletal complaints were more frequent with commercial binders. The frequency of skin changes was higher with noncommercial binders; however, acne was higher with commercial binders.</p><p><strong>Conclusions: </strong>Our results suggest that the positive mental health changes associated with chest binding outweigh the negative side effects. However, the contrariety of adverse effects among binding methods suggests that chest binding must be evaluated by individual binder type rather than as a general practice. These findings will help providers guide conversations to identify which binder is best for each unique patient, as well as encourage future research in chest binding best practices.</p>","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":" ","pages":"533-543"},"PeriodicalIF":2.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669614/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47282213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Transgender HealthPub Date : 2024-12-16eCollection Date: 2024-12-01DOI: 10.1089/trgh.2023.0032
Shelby A Smout, Jeanine P D Guidry, Eric G Benotsch
{"title":"Psychosocial Factors Inhibiting Timely COVID-19 Vaccination and Booster Receipt Among Transgender and Gender Diverse Adults.","authors":"Shelby A Smout, Jeanine P D Guidry, Eric G Benotsch","doi":"10.1089/trgh.2023.0032","DOIUrl":"10.1089/trgh.2023.0032","url":null,"abstract":"<p><strong>Purpose: </strong>The goal of this study was to assess possible psychosocial contributors to delayed coronavirus disease 2019 (COVID-19) vaccination within a sample of transgender and gender diverse (TGD) individuals.</p><p><strong>Methods: </strong>TGD participants (<i>N</i>=385) were recruited from Prolific.co. Survey items assessed COVID-19 vaccination status, experiences of discrimination in health care settings, medical mistrust, COVID-19 mistrust, and perceived barriers to vaccination. Logistic regressions were conducted using SPSS version 27 to assess whether demographic variables, medical mistrust, experiences of discrimination in health care, and COVID-19 mistrust predicted vaccination behaviors. A PATH model was developed using AMOS 21.0 to assess the relationship among experiences of discrimination, general medical mistrust, COVID-19 mistrust, and barriers to vaccination in predicting receipt of a booster at the time of the study.</p><p><strong>Results: </strong>Results from the logistic regressions indicated a binary TGD identity and higher COVID-19 mistrust predicted experiencing a delayed first dose of a COVID-19 vaccination and receipt of a booster at the time of the study over and above racial identity, experiences of discrimination, and general medical mistrust. Results from a PATH model indicated an association among experiences of discrimination in health care, medical mistrust, COVID-19 mistrust, barriers to vaccination, and having not received a booster at the time of the study.</p><p><strong>Conclusion: </strong>These findings support prior research demonstrating that vaccination rates among TGD individuals do not differ from other groups. However, TGD individuals with a binary gender may have experienced or anticipated experiencing barriers to COVID-19 vaccination and/or receipt of a booster. Public health and clinical implications for these findings are discussed.</p>","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":" ","pages":"565-572"},"PeriodicalIF":2.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44834449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Transgender HealthPub Date : 2024-12-16eCollection Date: 2024-12-01DOI: 10.1089/trgh.2023.0041
Jeb Jones, Gareth Butler, Meaghan Woody, Martha Sheets, Amanda D Castel, Paige Kulie, Ayden I Scheim, Sari L Reisner, Rachel Valencia, Minglun Wang, Rob Stephenson, Joanne D Stekler, Patrick S Sullivan
{"title":"Adaptation of a HIV Prevention Mobile App for Transmasculine People: A Pilot Acceptability and Feasibility Study.","authors":"Jeb Jones, Gareth Butler, Meaghan Woody, Martha Sheets, Amanda D Castel, Paige Kulie, Ayden I Scheim, Sari L Reisner, Rachel Valencia, Minglun Wang, Rob Stephenson, Joanne D Stekler, Patrick S Sullivan","doi":"10.1089/trgh.2023.0041","DOIUrl":"10.1089/trgh.2023.0041","url":null,"abstract":"<p><strong>Purpose: </strong>Using a community-engaged approach, we adapted a human immunodeficiency virus (HIV) prevention smartphone app, Transpire, to meet the HIV and sexually transmitted infection (STI) prevention needs of transgender men and other transmasculine people. We conducted a pilot study to assess the feasibility and acceptability of the app among participants in two cities in the southeastern United States.</p><p><strong>Methods: </strong>Participants were recruited online and through community partners. Eligible and consenting participants used the Transpire app for 3 months and completed surveys at the beginning and end of the follow-up period. Transpire gave participants access to HIV and STI prevention information; the ability to order HIV and STI at-home self-test kits, condoms, and lube; and mental health and substance use resources. The primary feasibility outcome was the System Usability Scale (SUS), which measures the usability of technology-based products.</p><p><strong>Results: </strong>Sixty participants were enrolled. Most were 18-24 years old (<i>n</i>=33, 55%) and identified as non-Hispanic white (<i>n</i>=46, 77%). The mean SUS score was 72.4, which meets established criteria for acceptability. Fifteen (32%) participants conducted an HIV test during the 3-month follow-up period and 2 (4%) initiated pre-exposure prophylaxis.</p><p><strong>Conclusions: </strong>Following a community-engaged adaptation process, the Transpire app was found to be acceptable in a pilot study conducted among transmasculine participants. These pilot data indicate that app-based interventions have the potential to increase awareness of and access to sexual health resources for transmasculine people. Additional studies will be needed to assess the efficacy of Transpire or similar apps to improve sexual health outcomes.</p>","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":" ","pages":"573-581"},"PeriodicalIF":2.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47081745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Transgender HealthPub Date : 2024-12-16eCollection Date: 2024-12-01DOI: 10.1089/trgh.2022.0190
Yohansa Fernández, Abigail Tapper, William Lodge, Don Operario
{"title":"The Utilization of Syndemic Theory in Transgender Literature: A Structured Literature Review.","authors":"Yohansa Fernández, Abigail Tapper, William Lodge, Don Operario","doi":"10.1089/trgh.2022.0190","DOIUrl":"10.1089/trgh.2022.0190","url":null,"abstract":"<p><strong>Purpose: </strong>Trans and gender diverse (TGD) people are one of the world's most marginalized populations. Current evidence indicates that ostracism faced by these communities leads to multiple adverse conditions. The synergistic impact of these conditions -a syndemic-has been well established among other marginalized populations. Despite disproportionate rates of syndemic conditions, there is a dearth of literature exploring their effect among TGD people. This review sought to summarize the current literature regarding syndemic conditions among this population.</p><p><strong>Methods: </strong>A comprehensive search of databases (Medline, Embase, Global Health, PsycInfo, and CINAHL) was conducted; search terms included syndemics, syndemic theory, transgender, sexual minority, and gender minority. References within selected articles were also reviewed. Inclusion criteria for this review included studies that (1) explored the impact of syndemic factors and/or theory among TGD people, (2) were written in English, and (3) published up to December 2020.</p><p><strong>Results: </strong>The search generated 192 articles; 10 met the inclusion criteria. Substance use, mental health, and victimization were the most prominent syndemic conditions assessed. Current evidence is limited to sexual risk behaviors and provides preliminary support for an association between syndemic conditions and sexual risk behaviors.</p><p><strong>Conclusion: </strong>Understanding syndemics is vital to developing contextually suitable interventions or TGD people. Future researchers should work toward longitudinal or high-level modeling approaches of syndemic theory to effectively design interventions to improve health outcomes among TGD people. Furthermore, scholars should study the relationship between syndemic conditions and other outcomes to better understand the impact of syndemics on broader health consequences.</p>","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":"1 1","pages":"522-532"},"PeriodicalIF":2.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"60538558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Stigma and Substance Use Among Transgender and Nonbinary Young Adults: Results from the Phoenix Study.","authors":"Don Operario, Wesley King, Kristi Gamarel, Mariko Iwamoto, Sandy Tan, Tooru Nemoto","doi":"10.1089/trgh.2022.0144","DOIUrl":"10.1089/trgh.2022.0144","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this research study was to describe and compare the prevalence of substance use behaviors in a sample of transgender and nonbinary young adults by gender subgroup (transgender men, transgender women, nonbinary people), and to examine relationships between substance use behaviors, racism, and antitransgender stigma.</p><p><strong>Methods: </strong>This was an analysis of a cross-sectional sample of 215 transgender and nonbinary young adults recruited from the San Francisco Bay area between January 2019 and July 2021. We used multivariable regression models to examine associations between self-reported experiences of antitransgender stigma, racism, and substance use behaviors.</p><p><strong>Results: </strong>Approximately half of the total sample reported recent heavy episodic drinking (52.8%) and club drug use (50.5%); 19.2% reported daily tobacco use, and 35.7% reported daily marijuana use. There were no gender differences in substance use behaviors. Antitransgender stigma was associated with daily marijuana use, heavy episodic drinking, and club drug use (cocaine, amphetamines, hallucinogens). Black/African American participants were more likely to report daily tobacco use and recent heavy episodic drinking than White participants, and multiracial/multiethnic participants reported greater levels of daily tobacco use compared with White participants. In addition to these main effects, a significant interaction between antitransgender stigma and racism on daily marijuana was found, suggesting risk exacerbation due to intersecting stigmas for participants of color.</p><p><strong>Conclusion: </strong>Findings demonstrate a need for prevention and treatment interventions addressing linkages between antitransgender stigma, racism, and substance use behaviors among transgender and nonbinary young adults.</p>","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":"1 1","pages":"317-325"},"PeriodicalIF":2.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11456760/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"60538543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Transgender HealthPub Date : 2024-01-31eCollection Date: 2024-02-01DOI: 10.1089/trgh.2021.0210
Atoosa Ghofranian, Devora Aharon, Jenna Friedenthal, William J Hanley, Joseph A Lee, Margaret Daneyko, Zoe Rodriguez, Joshua D Safer, Alan B Copperman
{"title":"Family Building in Transgender Patients: Modern Strategies with Assisted Reproductive Technology Treatment.","authors":"Atoosa Ghofranian, Devora Aharon, Jenna Friedenthal, William J Hanley, Joseph A Lee, Margaret Daneyko, Zoe Rodriguez, Joshua D Safer, Alan B Copperman","doi":"10.1089/trgh.2021.0210","DOIUrl":"10.1089/trgh.2021.0210","url":null,"abstract":"<p><strong>Purpose: </strong>Transgender and gender diverse (TGD) individuals continue to face adversity, stigma, and inequality, especially in health care. This study aimed to characterize the experience of TGD people and partners of TGD people with regard to fertility treatment.</p><p><strong>Methods: </strong>All TGD patients presenting to a single academic center between 2013 and 2021 were included. Baseline demographics collected included patient age, body mass index, anti-Mullerian hormone, basal antral follicle count, history of gender-affirming surgery, and/or gender-affirming hormone therapy. Outcomes included total patients who progressed to treatment, cycle type(s), and clinical outcomes.</p><p><strong>Results: </strong>In total, 82 patients who identified as TGD or had a partner who identified as TGD presented to care seeking fertility treatment. Of the 141 planned cycles, 106 (75.2%) progressed to treatment. Of the 15 <i>in vitro</i> fertilization (IVF) and co-IVF cycles, 12 achieved live birth. Of the 76 intrauterine inseminations 7 patients were discharged with ongoing pregnancies and one achieved live birth.</p><p><strong>Conclusion: </strong>These findings reaffirm that TGD individuals utilize the entire array of fertility services. With recent advances in access to care and modern medicine, assisted reproductive technology treatment has the power to support TGD patients in building contemporary family structures.</p>","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":"1 1","pages":"76-82"},"PeriodicalIF":2.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10835155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"60538504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gabriel “Gabi” B. Gonzalez, E. Dusic, Don Operario, Mariebeth B. Velásquez, A. Restar
{"title":"Structural and Social Inclusivity of Transgender and Nonbinary Students in U.S. Medical Schools and Schools of Public Health Programming","authors":"Gabriel “Gabi” B. Gonzalez, E. Dusic, Don Operario, Mariebeth B. Velásquez, A. Restar","doi":"10.1089/trgh.2022.0076","DOIUrl":"https://doi.org/10.1089/trgh.2022.0076","url":null,"abstract":"","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":"55 18","pages":""},"PeriodicalIF":2.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139385180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Madison Kolbow, Jade Cohen, S. Prathibha, S. Marmor, Marie-Claire Buckley, J. Hui
{"title":"Incidental Atypia in Patients Undergoing Chest Masculinization Surgery: An Observational Series","authors":"Madison Kolbow, Jade Cohen, S. Prathibha, S. Marmor, Marie-Claire Buckley, J. Hui","doi":"10.1089/trgh.2023.0011","DOIUrl":"https://doi.org/10.1089/trgh.2023.0011","url":null,"abstract":"","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":"16 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2023-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139149325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michael Ha, L. Ngaage, Emily R. Finkelstein, Caroline Simon, Nicholas Hricz, Kevin Y. Zhu, Joshua Yoon, Fan Liang, Jens Berli, Yvonne Rasko
{"title":"Gender-Affirmation Surgery Training in United States Academic Plastic Surgery Residency Programs","authors":"Michael Ha, L. Ngaage, Emily R. Finkelstein, Caroline Simon, Nicholas Hricz, Kevin Y. Zhu, Joshua Yoon, Fan Liang, Jens Berli, Yvonne Rasko","doi":"10.1089/trgh.2022.0206","DOIUrl":"https://doi.org/10.1089/trgh.2022.0206","url":null,"abstract":"","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":"111 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138975507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Transgender HealthPub Date : 2023-12-13eCollection Date: 2023-12-01DOI: 10.1089/trgh.2021.0187
Sophie M Cannon, Laramie R Smith, Donna M Jacobsen, Michelle T Valderama, Jordan Silva, Jill Blumenthal
{"title":"Assessing Knowledge of, Experience with, and Willingness to Prescribe Hormone Therapy to Transgender Individuals with HIV: A National Survey of HIV Practitioners.","authors":"Sophie M Cannon, Laramie R Smith, Donna M Jacobsen, Michelle T Valderama, Jordan Silva, Jill Blumenthal","doi":"10.1089/trgh.2021.0187","DOIUrl":"10.1089/trgh.2021.0187","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to determine if human immunodeficiency virus (HIV) practitioners offer gender-affirming hormone therapy (GAHT) to their transgender patients living with HIV, as previous studies have shown that these patients are more likely to be virally suppressed and retained in care.</p><p><strong>Methods: </strong>We conducted an online survey sent to 2570 HIV practitioners who attended an International Antiviral Society-USA event between 2017 and 2019. We also assessed demographics, transgender care training, comfort, prescribing practices, and knowledge.</p><p><strong>Results: </strong>Respondents (<i>N</i>=385) were mainly primary care (49%) and infectious disease (ID)/HIV (42%) practitioners. Fifty-seven percent prescribed GAHT to transgender people living with HIV, but only 7% received formal training. Thirty-five percent were ID/HIV, 60% were primary care, and 5% were other specialty practitioners. Most felt that it would be beneficial to have formal education in GAHT practices during training (83%). There were statistically significant differences in GAHT education, experiences, knowledge, and interest in future training and prescribing by health care specialty. Commonly cited barriers to providing therapy included lack of training (33%), lack of transgender people living with HIV in practice (18%), and lack of qualified mental health professionals (15%).</p><p><strong>Conclusion: </strong>This survey is the first to assess GAHT practices among HIV practitioners from across the United States. The majority of those surveyed prescribe GAHT to their transgender patients living with HIV. Although most felt comfortable doing so, few had formal training and knowledge scores were low. We advocate for the integration of GAHT education into formal training programs and offer resources for those who wish to pursue education.</p>","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":"1 1","pages":"534-541"},"PeriodicalIF":2.0,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10732173/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41458460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}